Appetite‐stimulating effects of once‐daily omeprazole in cats with chronic kidney disease: Double‐blind, placebo‐controlled, randomized, crossover trial

Journal of Veterinary Internal Medicine ◽

10.1111/jvim.16268 ◽

2021 ◽

Author(s):

Ashley Spencer ◽

Jessica M. Quimby ◽

Josh M. Price ◽

Sally MacLane ◽

Shanna Hillsman ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Crossover Trial ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo ◽

Randomized Crossover Trial

Download Full-text

A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease

Kidney International ◽

10.1046/j.1523-1755.2003.00124.x ◽

2003 ◽

Vol 64 (2) ◽

pp. 632-640 ◽

Cited By ~ 30

Author(s):

Nina Vasavada ◽

Chandan Saha ◽

Rajiv Agarwal

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Crossover Trial ◽

Loop Diuretics ◽

Double Blind ◽

Randomized Crossover Trial

Download Full-text

Faculty Opinions recommendation of High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954671.793466054 ◽

2012 ◽

Author(s):

John Eisman

Keyword(s):

Chronic Kidney Disease ◽

Parathyroid Hormone ◽

Kidney Disease ◽

Controlled Trial ◽

High Dose ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.735542506.793559665 ◽

2019 ◽

Author(s):

Carmine Zoccali ◽

Davide Bolignano

Keyword(s):

Type 2 Diabetes ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Glycaemic Control ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Lowering Effect

Download Full-text

FP413EFFECT OF VITAMIN D SUPPLEMENTATION ON VASCULAR FUNCTION, ENDOTHELIAL AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL

Nephrology Dialysis Transplantation ◽

10.1093/ndt/gfv177.12 ◽

2015 ◽

Vol 30 (suppl_3) ◽

pp. iii205-iii208

Author(s):

Ashok Kumar Yadav ◽

Vivek Kumar ◽

Vinod Kumar ◽

Manphool Singhal ◽

Anupam Lal ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Vitamin D ◽

Kidney Disease ◽

Vascular Function ◽

Controlled Trial ◽

Vitamin D Supplementation ◽

Inflammatory Biomarkers ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial

Yearbook of Urology ◽

10.1016/s0084-4071(08)79154-1 ◽

2008 ◽

Vol 2008 ◽

pp. 193-195

Author(s):

A. Shindel

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Crossover Trial ◽

Sildenafil Citrate ◽

Intravenous Nitroglycerin ◽

Double Blind ◽

Double Blind Placebo ◽

Randomized Crossover Trial ◽

Artery Disease

Download Full-text

Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial

The Lancet Diabetes & Endocrinology ◽

10.1016/s2213-8587(20)30162-5 ◽

2020 ◽

Vol 8 (7) ◽

pp. 582-593 ◽

Cited By ~ 17

Author(s):

David Z I Cherney ◽

Claire C J Dekkers ◽

Sean J Barbour ◽

Daniel Cattran ◽

Abdul Halim Abdul Gafor ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Crossover Trial ◽

Sglt2 Inhibitor ◽

Diabetic Patients ◽

Double Blind

Download Full-text

FP008ACHIEVEMENT OF NORMAL SERUM POTASSIUM WITH SODIUM ZIRCONIUM CYCLOSILICATE (ZS-9) IN A SUBGROUP OF PATIENTS WITH STAGE 4/5 CHRONIC KIDNEY DISEASE AND BASELINE POTASSIUM ≥5.5 MMOL/L FROM THE PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED HARMONIZE STUDY

Nephrology Dialysis Transplantation ◽

10.1093/ndt/gfv165.08 ◽

2015 ◽

Vol 30 (suppl_3) ◽

pp. iii68-iii68

Author(s):

Simon D. Roger ◽

Angel de Francisco ◽

Henrik Rasmussen ◽

Philip Lavin ◽

Bhupinder Singh ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Serum Potassium ◽

Normal Serum ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Sodium Zirconium ◽

Stage 4 ◽

Sodium Zirconium Cyclosilicate

Download Full-text

Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial

The Lancet ◽

10.1016/s0140-6736(19)32135-x ◽

2019 ◽

Vol 394 (10208) ◽

pp. 1540-1550 ◽

Cited By ~ 44

Author(s):

Rajiv Agarwal ◽

Patrick Rossignol ◽

Alain Romero ◽

Dahlia Garza ◽

Martha R Mayo ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Resistant Hypertension ◽

Controlled Trial ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III–IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial

Trials ◽

10.1186/s13063-019-3563-5 ◽

2019 ◽

Vol 20 (1) ◽

Cited By ~ 1

Author(s):

Jing Gan ◽

Yansheng Wu ◽

Xuezhong Gong ◽

Yiyi Ma ◽

Shengqiang Yu ◽

...

Keyword(s):

Clinical Trial ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Autosomal Dominant ◽

Polycystic Kidney ◽

Double Blind ◽

Double Blind Placebo ◽

Autosomal Dominant Polycystic Kidney ◽

Disease Study ◽

Disease Stages

Download Full-text

Effects of Resveratrol Supplementation in Nrf2 and NF-κB Expressions in Nondialyzed Chronic Kidney Disease Patients: A Randomized, Double-Blind, Placebo-Controlled, Crossover Clinical Trial

Journal of Renal Nutrition ◽

10.1053/j.jrn.2016.06.005 ◽

2016 ◽

Vol 26 (6) ◽

pp. 401-406 ◽

Cited By ~ 22

Author(s):

Juliana F. Saldanha ◽

Viviane O. Leal ◽

Felipe Rizzetto ◽

Gustavo H. Grimmer ◽

Marcelo Ribeiro-Alves ◽

...

Keyword(s):

Clinical Trial ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Double Blind ◽

Double Blind Placebo

Download Full-text